藥疹患者臨床特征分析及補體系統(tǒng)異?；罨奶接?/h1>
2017-06-01 05:57于均峰尚佩生張文娟沈曉峰
中國醫(yī)藥導報 2017年11期 關(guān)鍵詞：藥疹
于均峰++尚佩生+++張文娟++沈曉峰
[摘要] 目的 了解近年烏魯木齊市藥疹患者的臨床特征，檢測不同類型藥疹患者及健康對照者血清中IgG、IgE、IgA、C3、C4、CIC水平，初步探討補體系統(tǒng)活化在在藥疹發(fā)病機制中的作用。 方法 收集2013年12月～2015年12月新疆醫(yī)科大學第一、第五附屬醫(yī)院皮膚科病房62例藥疹患者，包括52例輕型藥疹患者（藥物性皮炎組）及10例重癥藥疹患者（重癥藥疹組），并選擇新疆醫(yī)科大學第五附屬醫(yī)院體檢中心健康人群30名作為健康對照組。采集上述藥疹患者急性期血清以及對照人群血清，采用酶聯(lián)免疫吸附試驗（ELISA）檢測血清中IgG、IgE、IgA、C3、C4、CIC濃度。 結(jié)果 引起藥疹的致敏藥中抗生素所占比例最大，共有32例，約占總數(shù)的51.61%；其次為中藥注射劑，共有18例，占29.03%。兩組藥疹患者的血清IgG水平均低于健康對照組（P < 0.05），IgE含量均高于健康對照組（P < 0.05），而且重癥藥疹組患者入院時IgE水平高于藥物性皮炎組（P < 0.05）。藥疹患者血清中C3含量低于健康對照組，CIC含量高于健康對照組，而且重癥藥疹組入院時CIC含量高于藥物性皮炎組，差異均有統(tǒng)計學意義（P < 0.05）。 結(jié)論 補體系統(tǒng)的異常活化尤其是C3的消耗及CIC的沉積在藥疹的發(fā)病機制中具有一定意義。
[關(guān)鍵詞] 藥疹；補體系統(tǒng)；致敏藥物
[中圖分類號] R758 [文獻標識碼] A [文章編號] 1673-7210（2017）04（b）-0115-04
[Abstract] Objective To investigate the clinical characters of patient with drug eruption， detect the serum levels of IgG， IgE， IgA， C3， C4 and CIC in the patients and healthy control， preliminary discuss the role of complement system in pathogenesis of drug eruption. Methods 62 patients with drug eruption in Dermatology Wards of the First Affiliated Hospitals of Xinjiang Medical University and the Fifth Affiliated Hospitals of Xinjiang Medical University from December 2013 to December 2015 were selected， including 10 patients with severe drug eruption （severe drug eruption group）， and 52 patients with mild drug eruption （dermatitis medicamentosa group）. At the same time 30 healthy controls in Physical Examination Center of the Fifth Affiliated Hospitals of Xinjiang Medical University were selected as the healthy control group. The serum of acute stage patients and healthy controls were collected. The levels of IgG， IgE， IgA， C3， C4 and CIC in serum were determined by enzyme-linked immunosorbent assay. Results Antibiotics was the main sensitizer in drug eruption， the proportion was 51.61% （32 cases）. The second sensitizer was traditional Chinese medicine preparation， the proportion was 29.03% （18 cases）. Serum levels of IgG in patients with drug eruption were lower than those in the healthy control group （P < 0.05）， while levels of IgE were higher than those in the healthy control group （P < 0.05）， and level of IgE in patients at admission of the severe drug eruption group was higher than that in the dermatitis medicamentosa group （P < 0.05）. The levels of C3 in patients with drug eruption were lower than those in the healthy control group， levels of CIC were higher than those in the healthy control group， and level of CIC in patients at admission of the severe drug eruption group was higher than that in the dermatitis medicamentosa group， with statistically significant differences （P < 0.05）. Conclusion The abnormal activation of complement system especially the consumption of C3 and deposition of CIC may play an important role in the pathogenesis of drug eruption.
猜你喜歡
藥疹雖小，可不要大意保健醫(yī)苑(2022年2期)2022-03-06 亂吃消炎藥 當心重癥藥疹保健與生活(2021年18期)2021-09-17 1 883例住院藥疹患者致敏藥物分析中華臨床免疫和變態(tài)反應雜志(2017年3期)2017-03-22 婦科手術(shù)前使用苯巴比妥術(shù)后致固定性藥疹（附1例報告）淮海醫(yī)藥(2015年2期)2016-01-12 22例大皰性表皮松解壞死型藥疹皮損處理臨床回顧實用皮膚病學雜志(2015年4期)2015-12-22 重癥藥疹預后影響因素及臨床特征分析中國當代醫(yī)藥(2015年33期)2015-03-01 職業(yè)性三氯乙烯藥疹樣皮炎中華皮膚科雜志(2014年4期)2014-12-19 甲磺酸伊馬替尼致扁平苔蘚樣藥疹二例中華皮膚科雜志(2014年4期)2014-12-19 腫瘤壞死因子拮抗劑治療重癥三氯乙烯藥疹樣皮炎中華皮膚科雜志(2014年4期)2014-12-19 185例藥疹臨床分析*天津藥學(2013年3期)2013-04-19
于均峰++尚佩生+++張文娟++沈曉峰
[摘要] 目的 了解近年烏魯木齊市藥疹患者的臨床特征，檢測不同類型藥疹患者及健康對照者血清中IgG、IgE、IgA、C3、C4、CIC水平，初步探討補體系統(tǒng)活化在在藥疹發(fā)病機制中的作用。 方法 收集2013年12月～2015年12月新疆醫(yī)科大學第一、第五附屬醫(yī)院皮膚科病房62例藥疹患者，包括52例輕型藥疹患者（藥物性皮炎組）及10例重癥藥疹患者（重癥藥疹組），并選擇新疆醫(yī)科大學第五附屬醫(yī)院體檢中心健康人群30名作為健康對照組。采集上述藥疹患者急性期血清以及對照人群血清，采用酶聯(lián)免疫吸附試驗（ELISA）檢測血清中IgG、IgE、IgA、C3、C4、CIC濃度。 結(jié)果 引起藥疹的致敏藥中抗生素所占比例最大，共有32例，約占總數(shù)的51.61%；其次為中藥注射劑，共有18例，占29.03%。兩組藥疹患者的血清IgG水平均低于健康對照組（P < 0.05），IgE含量均高于健康對照組（P < 0.05），而且重癥藥疹組患者入院時IgE水平高于藥物性皮炎組（P < 0.05）。藥疹患者血清中C3含量低于健康對照組，CIC含量高于健康對照組，而且重癥藥疹組入院時CIC含量高于藥物性皮炎組，差異均有統(tǒng)計學意義（P < 0.05）。 結(jié)論 補體系統(tǒng)的異常活化尤其是C3的消耗及CIC的沉積在藥疹的發(fā)病機制中具有一定意義。
[關(guān)鍵詞] 藥疹；補體系統(tǒng)；致敏藥物
[中圖分類號] R758 [文獻標識碼] A [文章編號] 1673-7210（2017）04（b）-0115-04
[Abstract] Objective To investigate the clinical characters of patient with drug eruption， detect the serum levels of IgG， IgE， IgA， C3， C4 and CIC in the patients and healthy control， preliminary discuss the role of complement system in pathogenesis of drug eruption. Methods 62 patients with drug eruption in Dermatology Wards of the First Affiliated Hospitals of Xinjiang Medical University and the Fifth Affiliated Hospitals of Xinjiang Medical University from December 2013 to December 2015 were selected， including 10 patients with severe drug eruption （severe drug eruption group）， and 52 patients with mild drug eruption （dermatitis medicamentosa group）. At the same time 30 healthy controls in Physical Examination Center of the Fifth Affiliated Hospitals of Xinjiang Medical University were selected as the healthy control group. The serum of acute stage patients and healthy controls were collected. The levels of IgG， IgE， IgA， C3， C4 and CIC in serum were determined by enzyme-linked immunosorbent assay. Results Antibiotics was the main sensitizer in drug eruption， the proportion was 51.61% （32 cases）. The second sensitizer was traditional Chinese medicine preparation， the proportion was 29.03% （18 cases）. Serum levels of IgG in patients with drug eruption were lower than those in the healthy control group （P < 0.05）， while levels of IgE were higher than those in the healthy control group （P < 0.05）， and level of IgE in patients at admission of the severe drug eruption group was higher than that in the dermatitis medicamentosa group （P < 0.05）. The levels of C3 in patients with drug eruption were lower than those in the healthy control group， levels of CIC were higher than those in the healthy control group， and level of CIC in patients at admission of the severe drug eruption group was higher than that in the dermatitis medicamentosa group， with statistically significant differences （P < 0.05）. Conclusion The abnormal activation of complement system especially the consumption of C3 and deposition of CIC may play an important role in the pathogenesis of drug eruption.
猜你喜歡
保健醫(yī)苑(2022年2期)2022-03-06
保健與生活(2021年18期)2021-09-17
中華臨床免疫和變態(tài)反應雜志(2017年3期)2017-03-22
淮海醫(yī)藥(2015年2期)2016-01-12
實用皮膚病學雜志(2015年4期)2015-12-22
中國當代醫(yī)藥(2015年33期)2015-03-01
中華皮膚科雜志(2014年4期)2014-12-19
中華皮膚科雜志(2014年4期)2014-12-19
中華皮膚科雜志(2014年4期)2014-12-19
天津藥學(2013年3期)2013-04-19
